use of central cannabinoid receptor antagonist for the herstelling of drugs to facilitate the task of the policy

摘要

The invention relates to the use of a medicinal kit comprising N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide for helping to quit tobacco consumption.